financetom
Business
financetom
/
Business
/
Eldorado Gold Up 0.33% In US After Hours As Updates on Lamaque Complex Report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eldorado Gold Up 0.33% In US After Hours As Updates on Lamaque Complex Report
Jan 27, 2025 2:57 PM

05:39 PM EST, 01/27/2025 (MT Newswires) -- Eldorado Gold ( EGO ) was at last look up 0.33% in US after trade Monday -- having lost near 2.5% during regular hours -- as it shared results of an updated technical report for the Lamaque Complex. A statement noted this included an updated life-of-mine plan based on Mineral Reserves from Triangle, Ormaque and Parallel and a Preliminary Economic Assessment extended LOM plan primarily based on Inferred Mineral Resources from Triangle and Ormaque.

The report outlines two scenarios --- the reserve case and the preliminary economic assessment case. In the first case, the company expects to produce 1.2 million ounces of gold over 8 years, with an average annual production of around 175,000 ounces through 2028. The life-of-mine All-In Sustaining Cost (AISC) is estimated at US$1,176 per ounce of gold, the company said.

The PEA Case, cites incremental gold production of 1.5 million ounces, showing the potential to extend mine life to 17 years through 2041. This maintains average annual production of about 185,000 ounces through 2036. In this extended scenario, the LOM AISC is slightly lower, at US$1,149 per ounce, and the mine could operate until 2041, the company said.

ELD was down $0.49 or 2.2% on the TSX, with many North America stock markets much lower on the day,

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4
Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4
May 13, 2024
12:59 PM EDT, 05/13/2024 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said Monday it is expanding the company's mast cell development portfolio and will evaluate briquilimab, a conditioning agent for patients undergoing stem cell transplant, in patients with asthma in phase 1b/2a study. Enrolling in the study is expected to start in Q4, according to the company. We plan...
Home Depot 'Well Positioned' Amid Macroeconomic Uncertainty, BofA Says
Home Depot 'Well Positioned' Amid Macroeconomic Uncertainty, BofA Says
May 13, 2024
12:53 PM EDT, 05/13/2024 (MT Newswires) -- Home Depot ( HD ) is well-positioned to gain market share amid choppy macroeconomic conditions, BofA Securities said in a note. While the macro remains choppy, and we expect continued pressure in 2024 on discretionary and big ticket, we expect HD to see continued share gains as it accelerates growth and capabilities with...
Meta exploring AI-assisted earbuds with cameras, The Information reports
Meta exploring AI-assisted earbuds with cameras, The Information reports
May 13, 2024
May 13 (Reuters) - Meta Platforms ( META ) is exploring making earphones powered by artificial intelligence with cameras, The Information reported on Monday citing employees familiar with the matter. A slew of companies, from startups to conglomerates including Meta, are looking to develop AI-based wearable devices to capture growing interest in the sector. The Facebook-parent expects the device, being...
Update: Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
Update: Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US
May 13, 2024
12:56 PM EDT, 05/13/2024 (MT Newswires) -- (Updates with Novo Nordisk ( NVO ) response in the fourth and fifth paragraphs, and stock movement in the final paragraph.) Novo Nordisk ( NVO ) , based in Denmark, has been asked by Bernie Sanders of Vermont to reduce the prices of its Ozempic and Wegovy drugs in the US, multiple media...
Copyright 2023-2026 - www.financetom.com All Rights Reserved